Cadrenal Therapeutics appoints Jeff Cole as COO with $405K salary and equity incentives

Cadrenal Therapeutics, Inc.

Jeff Cole appointed Chief Operating Officer, newly created role, effective Feb 8, 2024.
Annual base salary $405K, discretionary bonus up to 40% of base, and 150,000 stock options.
Cole brings 25+ years exp in pharma operations; previously at Espero BioPharma and Valeant.
He will oversee manufacturing, supply chain, IP, commercialization, partnering for tecarfarin.
Appointment comes as Cadrenal advances tecarfarin toward Phase 3 pivotal trial for anticoagulation.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Jeffrey Cole

Chief Operating Officer

CVKD · Cadrenal Therapeutics, Inc.

Effective: 2024-02-08
Filed: February 12, 2024, 6:59 PM ET

On February 6, 2024, Cadrenal Therapeutics, Inc. (the “Company”) entered into an offer letter agreement (the “Offer Letter”) with Jeffrey Cole describing the terms of his employment as the Company’s Chief Operating Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jeffrey Cole was appointed as Chief Operating Officer at Cadrenal Therapeutics, Inc..

Action: appointed
Role: Chief Operating Officer

Exact text from the filing

On February 6, 2024, Cadrenal Therapeutics, Inc. (the “Company”) entered into an offer letter agreement (the “Offer Letter”) with Jeffrey Cole describing the terms of his employment as the Company’s Chief Operating Officer.

View on SEC.gov

Cadrenal Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-24-012649

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.